sn-2 Palmitic Triglyceride Synthesis Without Solvent Purification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing triglycerides with high palmitic acid content in the sn-2 position for infant formula are economically unviable due to the need for solvent use and complex purification steps, and they fail to replicate the regio-specific distribution found in human breast milk.

Innovation Solution

A solvent-free, two-step enzymatic process using n-butanol for alcoholysis and selective lipases to produce triglycerides with over 70% palmitic acid in the sn-2 position, optimizing the ratio of specific triglycerides to match human breast milk profiles.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional methods are used to produce triglycerides with high palmitic acid content in sn-2 position, then the production cost increases and process complexity increases due to solvent use and purification steps, but the manufacturing precision and product quality can be maintained

Engineering Contradiction:
Improveregio-specific distribution of palmitic acid in sn-2 positionVSAvoidprocess complexity including solvent use and purification steps
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The process is divided into two distinct enzymatic steps: first alcoholysis to form 2-monopalmitin, then esterification to form the final triglyceride product. This segmentation allows each step to be optimized independently, achieving high sn-2 palmitic acid content without requiring complex solvent-based purification

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

2-Monopalmitin serves as an intermediate compound that facilitates the transformation from tripalmitin to the final triglyceride product. This intermediate allows the reaction to proceed through a controlled enzymatic pathway that achieves high regio-specificity without requiring harsh solvents or complex purification

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If conventional methods are used to produce triglycerides with high palmitic acid content in sn-2 position, then the production cost increases due to solvent use and purification steps, but the manufacturing precision can be maintained

Engineering Contradiction:
Improveregio-specific distribution of palmitic acid in sn-2 positionVSAvoideconomic viability of the process
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The enzymatic reactions are performed in a solvent-free system where the substrate itself serves as the reaction medium. The lipase enzymes catalyze the transformations directly in the lipid phase, eliminating the need for external solvents and complex purification steps, thereby reducing costs while maintaining high sn-2 palmitic acid content

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The process changes the reaction parameters by using enzymatic catalysis instead of chemical catalysis, and by performing reactions in a solvent-free lipid phase. This parameter change enables the reaction to proceed with high selectivity for sn-2 palmitic acid positioning while avoiding the need for expensive solvents and purification steps

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If conventional methods are used to produce triglycerides with high palmitic acid content in sn-2 position, then the environmental impact increases due to solvent use and purification steps, but the manufacturing precision can be maintained

Engineering Contradiction:
Improveregio-specific distribution of palmitic acid in sn-2 positionVSAvoidenvironmental impact from solvent use and purification
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The method converts the potential harm of requiring high-purity triglycerides with specific regio-distribution into a benefit by using enzymatic selectivity. The lipase enzymes naturally provide the required sn-2 specificity through their catalytic mechanism, eliminating the need for harmful solvent-based purification while achieving the same manufacturing precision

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The enzymatic system performs the purification function inherently through its selectivity. The lipase enzymes only catalyze reactions at specific positions (sn-2 for palmitic acid), automatically creating the desired regio-specific distribution without requiring external purification agents or solvents, thus eliminating environmental harm

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process achieves high purity and selectivity of triglycerides with palmitic acid in the sn-2 position, reducing costs and environmental impact while mimicking the nutritional benefits of human breast milk.

Implementation Method 1

The process comprises: a) alcoholysis of tripalmitin with n-butanol in the presence of a lipase to form 2-monopalmitin and butyl palmitate

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

a) alcoholysis of tripalmitin with n-butanol in the presence of a lipase to form 2-monopalmitin and butyl palmitate

Methodology Applied
Scientific EffectAlcoholysis reaction: Chemical Bonding

Implementation Method 3

b) esterification of 2-monopalmitin with oleic acid in the presence of a lipase to form OPO

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 4

b) esterification of 2-monopalmitin with oleic acid in the presence of a lipase to form OPO

Methodology Applied
Scientific EffectEsterification reaction: Chemical Bonding

Data Source

PatentEP4132282B1Method for manufacturing sn-2 palmitic triacylglycerols
Publication Date: 2025.12.03 SOCIETE DES PRODUITS NESTLE SA
  • EP4132282B1 patent drawingFigure 1~2
  • EP4132282B1 patent drawingFigure 3~4
  • EP4132282B1 patent drawingFigure 5

AI summary

The present invention concerns an enzymatic process for the preparation of a triglyceride ingredient comprising triglycerides present in human breast milk.